Home › Astrocytoma › Illinois › Chicago

Pag-aaral pangklinika para sa Astrocytoma sa Chicago, IL

9 pag-aaral para sa Astrocytoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Chicago (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Nagre-recruitPhase 3

University of Illinois, Chicago

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07215910

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Nagre-recruitPhase 1/2

Northwestern Memorial Hospital, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05765812

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Nagre-recruitPhase 1

Northwestern University, Chicago
University of Chicago Comprehensive Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06860594

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Nagre-recruitPhase 1/2

Research Site, Chicago

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05417594

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

Pag-aaral para sa Astrocytoma sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.